CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- 4 Open-market buy Director bought 3,000 shares at an average $2.99 ($8,958)
- 4 Open-market buy Chief Executive Officer bought 18,970 shares at an average $3.05 ($57,792)
- 4 Open-market buy Director bought 1,100 shares at an average $3.43 ($3,775)
- 4 Open-market buy Director bought 10,500 shares at an average $2.93 ($30,728)
- 4 Open-market buy Director bought 10,000 shares at an average $2.91 ($29,055)
- 4 Open-market buy Chief Executive Officer bought 30 shares at $2.97 ($89)
- 4 Open-market buy Director bought 2,000 shares at $2.89 ($5,780)
- 4 Open-market buy Director bought 4,200 shares at an average $2.97 ($12,464)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 10 of 10 · 200 filings